Document is current
Any future updates will be listed below
-
Authors
Floris, Alberto
Angioni, Maria Maddalena
Fadda, Mattia
Naitza, Micaela Rita
Congia, Mattia
Chessa, Elisabetta
Piga, Matteo
Cauli, Alberto
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 28 December 2024
First Online: 15 January 2025
Declarations
:
: This study was approved by the Local Ethical Committee (PROT. PG/2021/19418) of the Azienda Ospedaliero Universitaria of Cagliari and written informed consent was obtained from all participants.
: written informed consent for publication was obtained from all participants.
: A.F.: consulting and/or speaking fees from Amgen, Eli Lilly, Janssen, Abbvie. M.C.: consulting and/or speaking fees from Amgen, Eli Lilly, Novartis. A.C.: consulting and/or speaking fees from Abbvie, Amgen, Biogen, BMS, Galapagos, Eli Lilly, Janssen, Novartis, Pfizer, UCB. The other authors declare no conflicts of interest.
